Literature DB >> 21194270

A pilot double-blind randomised placebo-controlled trial of the effects of fixed-dose combination therapy ('polypill') on cardiovascular risk factors.

Masoud Majed1, Sina Moradmand Badie.   

Abstract

Year:  2011        PMID： 21194270     DOI： 011141/AIM.0020

Source DB:  PubMed          Journal:  Arch Iran Med        ISSN： 1029-2977            Impact factor:   1.354


× No keyword cloud information.
  3 in total

1.  Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.

Authors:  Abdullah Gandomkar; Hossein Poustchi; Maryam Moini; Mohsen Moghadami; Hadi Imanieh; Mohammad Reza Fattahi; Seyyed Mohammad Taghi Ayatollahi; Mohammad Mahdi Sagheb; Amir Anushiravani; Roozbeh Mortazavi; Sadaf Ghajarieh Sepanlou; Reza Malekzadeh
Journal:  Int J Public Health       Date:  2016-06-28       Impact factor: 3.380

Review 2.  The gastro-esophageal malignancies in Northern Iran research project: impact on the health research and health care systems in Iran.

Authors:  Sadaf G Sepanlou; Arash Etemadi; Farin Kamangar; Alireza Sepehr; Akram Pourshams; Hossein Poustchi; Farhad Islami; Alireza Sadjadi; Dariush Nasrollahzadeh; Shahryar Semnani; Farrokh Saidi; Christian C Abnet; Bruce Ponder; Paul D Pharoah; Nicholas E Day; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2013-01       Impact factor: 1.354

3.  Prevalence, awareness and risk factors of hypertension in a large cohort of Iranian adult population.

Authors:  Masoud M Malekzadeh; Arash Etemadi; Farin Kamangar; Hooman Khademi; Asieh Golozar; Farhad Islami; Akram Pourshams; Hossein Poustchi; Behrouz Navabakhsh; Mohammad Naemi; Paul D Pharoah; Christian C Abnet; Paul Brennan; Paolo Boffetta; Sanford M Dawsey; Alireza Esteghamati; Reza Malekzadeh
Journal:  J Hypertens       Date:  2013-07       Impact factor: 4.844
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.